New drug combo shows promise for Hard-to-Treat liver and lung cancers
NCT ID NCT04563338
First seen Mar 06, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study tests how well the drugs atezolizumab and bevacizumab work together in people with liver cancer or non-small cell lung cancer that has spread to the liver. About 36 adults will receive the drugs and be monitored for how long their cancer stays under control. Researchers will also collect blood and tumor samples to understand how the immune system responds to treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G2M9, Canada
Conditions
Explore the condition pages connected to this study.